10-Jul-2026
Wells Fargo Sticks to Its Buy Rating for Amrize Ltd (AMRZ)
TipRanks (Wed, 8-Jul 6:55 AM ET)
Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada
Business Wire (Fri, 19-Jun 10:30 AM ET)
Amrize Unveils $1 Billion Buyback—Signal of Confidence and Shareholder Value Focus
Market Chameleon (Tue, 5-May 3:11 AM ET)
Amrize Launches $1 Billion Share Buyback Program
Business Wire (Tue, 5-May 1:00 AM ET)
Market Chameleon (Thu, 30-Apr 3:13 AM ET)
Amrize Grows Revenue 4.7% in First Quarter and Reaffirms 2026 Guidance
Business Wire (Wed, 29-Apr 4:15 PM ET)
Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting
Business Wire (Tue, 21-Apr 4:15 PM ET)
Amrize Names Baris Oran CFO, Bringing Deep Experience to Steer Post-Spin-Off Growth
Market Chameleon (Wed, 1-Apr 3:55 AM ET)
Amrize is a building solutions company focused exclusively on the North American market. Amrize earns revenue from the sale of cement, aggregates, ready-mix concrete, asphalt, roofing systems, and other building solutions. The company is organized into two reportable segments: building materials and building envelope. The building materials business consists of Amrize's cement, aggregates, ready-mix concrete, and asphalt operations. The building envelope segment offers advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings, along with adhesives, tapes, and sealants.
Amrize trades on the NYSE stock market under the symbol AMRZ.
As of July 10, 2026, AMRZ stock price climbed to $50.75 with 1,832,499 million shares trading.
AMRZ has a beta of 0.85, meaning it tends to be less sensitive to market movements. AMRZ has a correlation of 0.09 to the broad based SPY ETF.
AMRZ has a market cap of $28.09 billion. This is considered a Large Cap stock.
Last quarter Amrize reported $2 billion in Revenue and -$.16 earnings per share. This beat revenue expectation by $41 million and missed earnings estimates by -$.01.
The top ETF exchange traded funds that AMRZ belongs to (by Net Assets): VXF, PAVE, VAW, IFRA, ITOT.
AMRZ has underperformed the market in the last year with a price return of +0.8% while the SPY ETF gained +21.8%. AMRZ has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.4% and -9.2%, respectively, while the SPY returned +11.4% and +3.6%, respectively.
AMRZ support price is $48.87 and resistance is $51.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRZ shares will trade within this expected range on the day.